1. Home
  2. REAX vs PHVS Comparison

REAX vs PHVS Comparison

Compare REAX & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REAX
  • PHVS
  • Stock Information
  • Founded
  • REAX 2018
  • PHVS 2015
  • Country
  • REAX United States
  • PHVS Switzerland
  • Employees
  • REAX N/A
  • PHVS N/A
  • Industry
  • REAX
  • PHVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • REAX
  • PHVS Health Care
  • Exchange
  • REAX Nasdaq
  • PHVS Nasdaq
  • Market Cap
  • REAX 849.5M
  • PHVS 980.9M
  • IPO Year
  • REAX N/A
  • PHVS 2021
  • Fundamental
  • Price
  • REAX $3.95
  • PHVS $22.99
  • Analyst Decision
  • REAX Strong Buy
  • PHVS Buy
  • Analyst Count
  • REAX 3
  • PHVS 6
  • Target Price
  • REAX $6.33
  • PHVS $37.17
  • AVG Volume (30 Days)
  • REAX 1.0M
  • PHVS 59.1K
  • Earning Date
  • REAX 08-07-2025
  • PHVS 08-13-2025
  • Dividend Yield
  • REAX N/A
  • PHVS N/A
  • EPS Growth
  • REAX N/A
  • PHVS N/A
  • EPS
  • REAX N/A
  • PHVS N/A
  • Revenue
  • REAX $1,417,877,000.00
  • PHVS N/A
  • Revenue This Year
  • REAX $44.55
  • PHVS N/A
  • Revenue Next Year
  • REAX $16.68
  • PHVS N/A
  • P/E Ratio
  • REAX N/A
  • PHVS N/A
  • Revenue Growth
  • REAX 81.30
  • PHVS N/A
  • 52 Week Low
  • REAX $3.80
  • PHVS $11.51
  • 52 Week High
  • REAX $6.75
  • PHVS $26.33
  • Technical
  • Relative Strength Index (RSI)
  • REAX 39.20
  • PHVS 67.31
  • Support Level
  • REAX $4.07
  • PHVS $17.63
  • Resistance Level
  • REAX $4.34
  • PHVS $26.33
  • Average True Range (ATR)
  • REAX 0.18
  • PHVS 1.70
  • MACD
  • REAX -0.03
  • PHVS 0.65
  • Stochastic Oscillator
  • REAX 1.48
  • PHVS 65.24

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: